Investment will enable pHion to progress its lead program into the clinic
Drug Discovery World
JUNE 7, 2023
Compared with traditional mRNA vaccine delivery platforms, the RALA platform has the added advantage of ease of scalability and logistics, including stability at room temperature. pHion’s pipeline also includes differentiated therapeutic vaccines for the treatment of ovarian (PTX_V5) and prostate (PTX_V3) cancers.
Let's personalize your content